On October 9, Keith Buchanan, Senior Portfolio Manager at GLOBALT Investments, appeared on CNBC and stated that the markets show mixed signals of risk and optimism. Buchanan explained that he views the market in colliding ways that make him more concerned about the action over the next quarter or so. What is taught is how stretched and narrow the market has become. He acknowledged that the storyline of a narrow market has existed for some time but now sees increased risk on the horizon from a fiscal and geopolitical standpoint, as well as potential downside risk from an earnings standpoint. The markets are currently viewed as stretched between new all-time highs, specifically mentioning four new highs during a government shutdown, where fiscal problems are constantly visible, and the simultaneous movement of gold making new highs in a way that looks parabolic. This presents two totally different narratives of risk and optimism simultaneously, leading to concern about the market’s future direction.
Regarding tech, earnings estimates have increased over the last couple of months. Specifically, since July, earnings estimates have risen for 3 sectors: communications services, tech, and financials. Buchanan acknowledged that this trend is a roadmap for where investors should put their money, and recalled that they were in the same position coming into the last earnings season, which displayed an incredible income-stable resilience from US corporations. This performance, in Buchanan’s opinion, justified some of the valuation, particularly among the larger, higher-growing corporations whose earnings and cash flow fulfilled the optimism the market held. Now, coming into another earnings season, the market is at a precipice where a follow-through of evidence is needed, meaning earnings and cash flow must justify the current valuations, particularly for the largest names that hold the most weight in the major indices.
That being said, we’re here with a list of the 14 best high volume stocks to buy according to Wall Street analysts.
Our Methodology
We first used the Yahoo stock screener to compile a list of stocks with high average 3-month volumes (at least 10 million). We then selected the 14 stocks with an upside potential of over 35%. The stocks are ranked in ascending order of their upside potential. We have also added the hedge fund sentiment for each stock, as of Q2 2025, which was sourced from Insider Monkey’s database.
Note: All data was sourced on October 15.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 427.7% since May 2014, beating its benchmark by 264 percentage points (see more details here).
14 Best High Volume Stocks to Buy According to Wall Street Analysts
14. Kenvue Inc. (NYSE:KVUE)
Average Volume (3-Month): 26.632 million
Number of Hedge Fund Holders: 72
Average Upside Potential as of October 15: 25.19%
Kenvue Inc. (NYSE:KVUE) is one of the best high volume stocks to buy according to Wall Street analysts. On October 10, JPMorgan lowered the price target on Kenvue to $21 from $24, while maintaining an Overweight rating on the shares as part of a Q3 2025 preview for the household, personal care, and beauty group. JPMorgan believes that most large-cap companies in the said group will report another weak quarter due to the depressed consumer demand in the US and decelerating trends for Western Europe. This backdrop is further worsened as retailers are actively reducing inventory as well.
Earlier on October 9, Citi also lowered the firm’s price target on the company to $17 from $20, while keeping a Neutral rating on the shares due to a similar sentiment on the group. The firm sees a challenging backdrop for the beverage, household, and personal care group heading into Q3 as trends in the US remain soft.
Kenvue Inc. (NYSE:KVUE) operates as a consumer health company in the US, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health.
13. Carnival Corporation & plc (NYSE:CCL)
Average Volume (3-Month): 19.622 million
Number of Hedge Fund Holders: 69
Average Upside Potential as of October 15: 25.82%
Carnival Corporation & plc (NYSE: CCL) is one of the best high volume stocks to buy according to Wall Street analysts. On October 15, Tigress Financial raised the firm’s price target on Carnival to $40 from $38 and kept a Buy rating on the shares as the firm noted the company’s recently reported record Q3 2025 results. The analyst also added that forward bookings and guest deposits at these record levels give the company revenue visibility into 2026.
The firm’s 12-month price target represents a potential upside of close to 38% from current levels. In Q3 2025, Carnival Corporation achieved an all-time high net income of $2 billion, which surpassed the pre-pandemic benchmark by ~10%.
Carnival also raised its full-year 2025 net income guidance for the third time, now anticipating ~$2.9 billion or $2.14 per share to reach ~$7.1 billion, a 15% improvement over 2024. CEO Josh Weinstein confirmed that demand remains strong, with record pricing levels for both North American and European bookings, and bookings for 2026 are nearly half full at higher prices, with 2027 bookings off to a record start.
Carnival Corporation & plc (NYSE:CCL) is a cruise company that provides leisure travel services in North America, Australia, Europe, and internationally. The company operates through four segments: NAA Cruise Operations, Europe Cruise Operations, Cruise Support, and Tour & Other.
12. Keurig Dr Pepper Inc. (NASDAQ:KDP)
Average Volume (3-Month): 17.093 million
Number of Hedge Fund Holders: 46
Average Upside Potential as of October 15: 26.25%
Keurig Dr Pepper Inc. (NASDAQ:KDP) is one of the best high volume stocks to buy according to Wall Street analysts. On October 8, BofA lowered the firm’s price target on Keurig Dr Pepper to $33 from $41, while keeping a Buy rating on the shares. In a preview for the packaged food, beverages, HPC, and tobacco groups, BofA cut estimates for topline and EPS for Q3 2025; with a few exceptions; in the firm’s consumer staples coverage.
Earlier on October 1, TD Cowen analyst Robert Moskow also lowered the firm’s price target on the company to $28 from $36 with a Hold rating on the shares, as TD Cowen maintained its Q3 and 2025 EPS estimates and expects that Keurig Dr Pepper will reiterate guidance.
Keurig Dr Pepper Inc. (NASDAQ:KDP) owns, manufactures, and distributes beverages and single-serve brewing systems in the US and internationally. It operates through three segments: US Refreshment Beverages, US Coffee, and International.
11. PG&E Corporation (NYSE:PCG)
Average Volume (3-Month): 25.604 million
Number of Hedge Fund Holders: 77
Average Upside Potential as of October 15: 26.28%
PG&E Corporation (NYSE:PCG) is one of the best high volume stocks to buy according to Wall Street analysts. On October 9, BMO Capital analyst James Thalacker maintained his bullish stance on the company while giving a Buy rating to the company’s shares. Later on October 14, the firm raised the price target on PG&E Corporation to $25 from $23 with an Outperform rating on the shares. BMO Capital noted that the stock is trading at a deep discount currently despite top-tier EPS and rate base growth.
The firm anticipates that PG&E Corporation’s valuation will improve due to potential catalysts like achieving an investment-grade rating and increasing the company’s dividend yield. However, earlier on October 3, Jefferies lowered the price target on PG&E Corporation to $20 from $22 with a Buy rating on the shares. The company is Jefferies’ preferred California utility due to its risk/reward profile, lower projected wildfire risk, a 9% premium EPS CAGR through 2030, conservative EPS guidance, no need for new equity, messaging about share buybacks, and a discounted price-to-equity ratio.
PG&E Corporation (NYSE:PCG), through its subsidiary, Pacific Gas and Electric Company, sells and delivers electricity and natural gas to customers in northern and central California, the US.
10. Teva Pharmaceutical Industries Limited (NYSE:TEVA)
Average Volume (3-Month): 11.091 million
Number of Hedge Fund Holders: 57
Average Upside Potential as of October 15: 26.39%
Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best high volume stocks to buy according to Wall Street analysts. On October 10, the US FDA approved an expanded indication for UZEDY (risperidone) extended-release injectable suspension for subcutaneous use. This announcement was made by Teva Pharmaceutical Industries and Medincell grants approval for UZEDY as a monotherapy or as adjunctive therapy to lithium or valproate for the maintenance treatment of bipolar I disorder (BD-I) in adults.
This is a significant step toward addressing unmet needs for those living with BD-I, a serious mental health condition defined by episodes of mania and depression, affecting an estimated 1% (or 3,400,000+) of US adults in their lifetime. UZEDY is a long-acting formulation of risperidone that utilizes SteadyTeq, a proprietary copolymer technology from Medincell, which controls the steady release of the medication. Therapeutic blood concentrations are reached within 6-24 hours of a single dose.
For the newly approved BD-I indication, UZEDY is approved with three once-monthly dosing options: 50 mg, 75 mg, and 100 mg. For its prior indication, UZEDY is also available for use every one or two months for the treatment of schizophrenia in adults, an indication it received US approval in 2023. The FDA’s decision to expand UZEDY’s indication was based on existing clinical data for the drug.
Teva Pharmaceutical Industries Limited (NYSE:TEVA) develops, manufactures, markets, and distributes generic and other medicines and biopharmaceutical products in the US, Europe, Israel, and internationally.
9. Amcor (NYSE:AMCR)
Average Volume (3-Month): 23.224 million
Number of Hedge Fund Holders: 47
Average Upside Potential as of October 15: 26.79%
Amcor (NYSE:AMCR) is one of the best high volume stocks to buy according to Wall Street analysts. On October 15, Wells Fargo lowered the firm’s price target on Amcor to $9 from $11, while keeping an Overweight rating on the shares. Wells Fargo noted that packaging stocks like Amcor have largely lagged the broader market in Q3 2025, as sluggish volumes are a major obstacle. Even with most companies performing well, the firm doesn’t anticipate a significant positive change.
However, on October 10, Stifel analyst Lars Kjellberg upgraded Amcor to Buy from Hold, despite a slight cut on the price target to $10.20 from $10.83. This sentiment was announced due to the merger of Amcor and Berry, which happened earlier this year and created a consumer packaging company that the analyst believes to be quite large in scale. At the same time, Kjellberg noted that promised synergies will be challenging to deliver to the bottom line.
Amcor (NYSE:AMCR), together with its subsidiaries, produces and sells packaging products in Europe, North America, Latin America, and the Asia Pacific. The company operates in two segments: Global Flexible Packaging Solutions and Global Rigid Packaging Solutions.
8. Peloton Interactive Inc. (NASDAQ:PTON)
Average Volume (3-Month): 13.86 million
Number of Hedge Fund Holders: 53
Average Upside Potential as of October 15: 27.20%
Peloton Interactive Inc. (NASDAQ:PTON) is one of the best high volume stocks to buy according to Wall Street analysts. On October 14, Peloton and Twin Health announced a collaboration that integrates Peloton’s extensive fitness and wellness content into Twin Health’s AI Digital Twin program, which is designed to transform metabolic health.
The partnership grants Twin Health members access to Peloton’s expansive library of live and on-demand fitness classes. This content is directly integrated into each member’s hyper-personalized AI Digital Twin care plan, setting a new standard for metabolic health care. The AI Digital Twin uses data to recommend specific Peloton content to help members achieve their individual metabolic health goals.
Twin Health members will receive a Peloton App One membership at no additional cost. They will also have the option for a reduced-cost Peloton Bike+ rental or a Peloton All-Access membership. Twin’s continuous and precision-guided insights, together with Peloton’s expert-led content will help members achieve lasting health outcomes, sustain muscle mass, and safely reduce or discontinue costly medications like GLP-1s, without experiencing rebound weight gain.
Peloton Interactive Inc. (NASDAQ:PTON) provides fitness and wellness products and services in North America and internationally. The company offers a range of Connected Fitness products along with Peloton App memberships.
7. Petróleo Brasileiro S.A. – Petrobras (NYSE:PBR)
Average Volume (3-Month): 22.236 million
Number of Hedge Fund Holders: 39
Average Upside Potential as of October 15: 28.37%
Petróleo Brasileiro S.A. – Petrobras (NYSE:PBR) is one of the best high volume stocks to buy according to Wall Street analysts. On October 13, Bloomberg reported that Petrobras announced that it would resume offshore production at a platform located in one of its two largest oil fields, Tupi, potentially adding to a global supply glut that has crude oil prices hovering around $60 a barrel.
This restart involves the floating production vessel/FPSO known as the Cidade de Angra dos Reis, following the completion of work requested by Brazil’s National Agency of Petroleum, Natural Gas and Biofuels/ANP. The FPSO had previously produced 43,951 barrels per day in January before the ANP shut it down the following month due to safety concerns.
The vessel resumed operations this week after completing the necessary maintenance and compliance work ordered by the regulator earlier in the year. The resumption of production at the flagship Tupi field, a highly productive pre-salt asset, is expected to restore output by tens of thousands of barrels per day, returning it to pre-shutdown levels. Petrobras also plans to further optimize the field’s subsea network to ensure long-term, sustained flows.
Petróleo Brasileiro S.A. – Petrobras (NYSE:PBR) explores, produces, and sells oil and gas in Brazil and internationally. It operates through three segments: Exploration & Production; Refining, Transportation & Marketing; and Gas & Low Carbon Energies.
6. Comcast Corporation (NASDAQ:CMCSA)
Average Volume (3-Month): 23.553 million
Number of Hedge Fund Holders: 82
Average Upside Potential as of October 15: 28.68%
Comcast Corporation (NASDAQ:CMCSA) is one of the best high volume stocks to buy according to Wall Street analysts. On October 14, Comcast Technology Solutions, a division of Comcast Corporation, announced a partnership with Deutsche Telekom to introduce advanced whole-home WiFi Mesh technology across Europe.
The partnership brings Comcast’s cloud-based WiFi Mesh Platform, which is already deployed in North America and Europe, with Deutsche Telekom’s European market strength to provide Deutsche Telekom customers with seamless and intelligent connectivity via a self-optimising WiFi solution. The solution delivers reliable coverage and dynamically adapts to both device usage and the physical layout of the home.
The foundation of the collaboration is the Comcast Technology Solutions Connectivity Platform, which is a WiFi solution. The platform’s components include mesh agents for both gateways and extenders, hosted cloud orchestration, and a suite of public APIs for easy integration with Deutsche Telekom back-end and customer-facing systems.
Comcast Corporation (NASDAQ:CMCSA) is a media and technology company that operates through Residential Connectivity & Platforms, Business Services Connectivity, Media, Studios, and Theme Parks segments.
5. Chipotle Mexican Grill Inc. (NYSE:CMG)
Average Volume (3-Month): 20.33 million
Number of Hedge Fund Holders: 68
Average Upside Potential as of October 15: 31.66%
Chipotle Mexican Grill Inc. (NYSE:CMG) is one of the best high volume stocks to buy according to Wall Street analysts. On October 15, Morgan Stanley analyst Brian Harbour lowered the firm’s price target on Chipotle to $59 from $65 and maintained an Overweight rating on the shares. Harbour anticipated a softer Q3 2025 and reduced the firm’s Q3 and H2 estimates for the year.
The analyst also expects fiscal year same-store sales to be negative instead of the about flat prior guidance. A day prior, on October 14, Truist analyst Jake Bartlett also lowered the firm’s price target on the company to $53 from $60 and kept a Buy rating on the shares as part of a broader research note previewing a boring Q3 2025 among Restaurant names.
Additionally, Stephens analyst Jim Salera lowered the price target on Chipotle to $48 from $60 with an Equal Weight rating on the shares on October 13. The firm is revising estimates and price targets among its restaurant coverage as part of its Q3 preview for the group.
Chipotle Mexican Grill Inc. (NYSE:CMG), together with its subsidiaries, owns and operates Chipotle Mexican Grill restaurants.
4. CNH Industrial (NYSE:CNH)
Average Volume (3-Month): 12.7 million
Number of Hedge Fund Holders: 34
Average Upside Potential as of October 15: 36.25%
CNH Industrial (NYSE:CNH) is one of the best high volume stocks to buy according to Wall Street analysts. On October 8, Truist lowered the price target on CNH Industrial to $14 from $17 with a Buy rating on the shares. This sentiment came as part of a broader research note by Truist previewing Q3 2025 results in Machinery, Infrastructure Services, and Multi-Industry Industrial Technology.
The firm views Q3 as a mixed bag, with Machinery facing risks to margins in H2 relative to H1, as tariff headwinds are expected to be fully reflected in margins. But Machinery will ultimately get a pass as margin pressure from tariffs is expected to be contained to 2025 and offset in 2026.
Later on October 13, Robert W. Baird analyst Mircea Dobre maintained a Hold rating on the company and set a price target of $11. Similarly, Tami Zakaria of JPMorgan also kept a Hold rating on CNH Industrial with a $12 price target on October 14.
CNH Industrial (NYSE:CNH) is an equipment and services company that designs, produces, markets, sells, and finances agricultural and construction equipment in North America, Europe, the Middle East, Africa, South America, and the Asia Pacific. The company has three segments: Agriculture, Construction, and Financial Services.
3. DraftKings Inc. (NASDAQ:DKNG)
Average Volume (3-Month): 11.81 million
Number of Hedge Fund Holders: 66
Average Upside Potential as of October 15: 47.48%
DraftKings Inc. (NASDAQ:DKNG) is one of the best high volume stocks to buy according to Wall Street analysts. On October 13, Northland lowered the firm’s price target on DraftKings to $30 from $33 and kept an Underperform rating on the shares. The firm noted that massive funding rounds for Kalshi (raising $300 million, valuing it at $5 billion, and tracking $50 billion in annual volume) and Polymarket (securing a $2 billion investment from ICE, the owner of NYSE) signal the growing competitive threat prediction markets pose to sports betting companies.
Earlier on October 7, Mizuho lowered the price target on the company to $54 from $58, while maintaining an Outperform rating on the shares. Mizuho remains constructive on DraftKings’ long-term potential, but at the same time, the firm also believes that the estimates need to be adjusted lower in the near and medium term before the stock can see support.
DraftKings Inc. (NASDAQ:DKNG) operates as a digital sports entertainment and gaming company in the US and internationally. It provides online sports betting, daily fantasy sports, media, digital lottery courier, media, and other products, as well as retail sportsbooks.
2. Permian Resources Corporation (NYSE:PR)
Average Volume (3-Month): 11.98 million
Number of Hedge Fund Holders: 49
Average Upside Potential as of October 15: 54.98%
Permian Resources Corporation (NYSE:PR) is one of the best high volume stocks to buy according to Wall Street analysts. On October 9, RBC Capital raised the firm’s price target on Permian Resources to $18 from $17 with an Outperform rating. RBC Capital stated that the company’s Q3 2025 operational and financial results should be solid and consistent with past quarters, as well as the current consensus expectations.
RBC Capital believes that management should continue the current activity pace that delivers low-single digit organic oil growth with improving capital efficiencies. Later on October 13, Mizuho Securities analyst William Janela reiterated a Buy rating on the shares while setting a $19 price target.
Permian Resources Corporation (NYSE:PR) is an independent oil & natural gas company that develops crude oil and associated liquids-rich natural gas reserves in the US.
1. Moderna Inc. (NASDAQ:MRNA)
Average Volume (3-Month): 10.095 million
Number of Hedge Fund Holders: 39
Average Upside Potential as of October 15: 70.79%
Moderna Inc. (NASDAQ:MRNA) is one of the best high volume stocks to buy according to Wall Street analysts. On October 13, Moderna announced that promising clinical, safety, and translational data from its Phase 1/2 study evaluating the investigational immune-evasion targeted cancer antigen therapy/CAT mRNA-4359 would be presented at the 2025 European Society for Medical Oncology/ESMO Congress.
mRNA-4359 is an immune-evasion targeted CAT that encodes epitopes of two common immune escape pathways: PD-L1 and IDO1. Its dual mechanism of action is designed to elicit antigen-specific T-cell responses to both directly kill tumor cells expressing PD-L1 and IDO1, and deplete immunosuppressive cells in the tumor microenvironment, aiming to establish an immune-permissive state for sustained anti-tumor activity.
Across all evaluable patients, the therapy demonstrated an objective response rate of 24% and a disease control rate of 60%. It continues to be evaluated as a monotherapy and in combination with pembrolizumab in patients with advanced melanoma and non-small cell lung cancer/NSCLC.
Moderna Inc. (NASDAQ:MRNA) is a biotechnology company that provides messenger RNA medicines in the United States, Europe, and internationally.
While we acknowledge the potential of MRNA to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than MRNA and that has 100x upside potential, check out our report about this cheapest AI stock.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
